Publikationen von Enting, Roelien H.

van den Bent, Martin J., Baumert, Brigitta, Erridge, Sara C., Vogelbaum, Michael A., Nowak, Anna K. , Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter , Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang und Kros, Johan M. (2017) Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. The Lancet 390 (10103), S. 1645-1653. Volltext nicht vorhanden.

Reijneveld, Jaap C., Taphoorn, Martin J. B., Coens, Corneel, Bromberg, Jacoline E. C., Mason, Warren P., Hoang-Xuan, Khê, Ryan, Gail, Hassel, Mohamed Ben, Enting, Roelien H., Brandes, Alba A., Wick, Antje, Chinot, Olivier, Reni, Michele, Kantor, Guy, Thiessen, Brian, Klein, Martin, Verger, Eugenie, Borchers, Christian, Hau, Peter, Back, Michael, Smits, Anja, Golfinopoulos, Vassilis, Gorlia, Thierry, Bottomley, Andrew, Stupp, Roger und Baumert, Brigitta G. (2016) Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. The Lancet Oncology 17 (11), S. 1533-1542. Volltext nicht vorhanden.